AstraZeneca PLC - Investments

AstraZeneca PLC's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Investments" stands at -5.29 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025.

AstraZeneca PLC's third quarter result of -2.00 Billion USD for the item "Investments" represents an increase of 5.08 percent compared to it's second quarter result.

Also, AstraZeneca PLC's third quarter result of -2.00 Billion USD for the item "Investments" represents a decrease of -32.17 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), AstraZeneca PLC's third quarter result of -5.29 Billion USD for the item "Investments" represents a decrease of -10.14 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 2.59 Billion United States Dollars compared to the value the year prior.
The 1 year change is 2.59 Billion United States Dollars.
The 3 year change is -4.72 Billion United States Dollars.
The 5 year change is -6.87 Billion United States Dollars.

The Serie's long term average value is -1.45 Billion United States Dollars. It's latest available value, on 09/30/2025, is -3.83 Billion United States Dollars lower, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 12/31/2024, to it's latest available value, on 09/30/2025, is +2.69 Billion.
The Serie's change in United States Dollars from it's maximum value, on 03/31/2021, to it's latest available value, on 09/30/2025, is -7.88 Billion.